Article
Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patients.
Lung cancer (Amsterdam, Netherlands) - 1 Nov 2006
Han Sae-Won, Kim Tae-You, Lee Kyung-Hun, Hwang Pil Gyu, Jeon Yoon Kyung, Oh Do-Youn, Lee Se-Hoon, Kim Dong-Wan, Im Seock-Ah, Chung Doo Hyun, Heo Dae Seog, Bang Yung-Jue
Abstract excerpt
BACKGROUND: Clinical predictors including Asian, female, adenocarcinoma and never-smoker and epidermal growth factor mutation are associated with gefitinib responsiveness in non-small-cell lung cancer. Direct comparison between clinical predictors and EGFR mutation for their predictive power has...
Topics
- Adenocarcinoma
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents
- Asian People
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- ErbB Receptors
- Female
- Gefitinib
- Humans
- Lung Neoplasms
- Male